Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
- Procter & Gamble (PG) Misses Q2 EPS by 12c; Sees FY15 Core Earnings In-Line to Down Versus Prior Year
- Caterpillar (CAT) Misses Q4 EPS by 20c; Guides FY15 EPS Well Below the Street
- Fed Can Wait Longer on Rate Hike; Morgan Stanley Pushes Back 'Liftoff' Forecast to March 2016
- Pre-Open Stock Movers 01/27: (SIMG) (CRRC) (COMM) Higher; (MSFT) (CAT) (PG) (UTX) Lower (more...)
- Pfizer (PFE) Tops Q4 EPS by 1c; Issues Light FY15 Outlook
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Peabody Energy (BTU) Reports Q4 adj.-Loss of $1.21/Share, Offers FY15 Guidance
- Dover Corp. (DOV) Tops Q4 EPS by 7c; Will Divest Sargent Aerospace
- Lexmark (LXK) Misses Q4 EPS by 4c; Issues Light FY15 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!